Ftse Mib
38.692,10
0,26%
DAX
23.068,33
0,29%
S&P 500
5.770,20
0,55%
NASDAQ
18.196,22
0,70%
Bitcoin
81.786,31
-7,06%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Quoin Pharmaceuticals Ltd (QNRX) Quoin Pharmaceuticals Ltd (QNRX) Notizie

Quoin Pharmaceuticals Ltd

QNRX
0,3098
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 09:02:27
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
06/3/202514:00GLOBEQuoin Pharmaceuticals to Announce Fourth Quarter and..
04/3/202513:30GLOBEQuoin Pharmaceuticals Files U.S. and International Patent..
27/2/202522:16EDGAR2Form 8-K - Current report
27/2/202513:30GLOBEQuoin Pharmaceuticals Announces Highly Positive ‘Whole Body’..
25/2/202513:30GLOBEQuoin Pharmaceuticals Launches First Episode of “NETHERTON..
04/2/202522:30EDGAR2Form 8-K - Current report
04/2/202513:30GLOBEQuoin Pharmaceuticals Launches ‘NETHERTON NOW’ Campaign to..
28/1/202522:44EDGAR2Form SCHEDULE 13D/A - General Statement of Acquisition of..
23/1/202522:15EDGAR2Form 8-K - Current report
23/1/202514:30GLOBEQuoin Pharmaceuticals Announces Further Clinical Evidence of..
16/1/202522:30EDGAR2Form 8-K - Current report
14/1/202514:30GLOBEQuoin Pharmaceuticals Announces Further Positive Clinical..
07/1/202520:29GLOBEPRISM MarketView Spotlights Quoin Pharmaceuticals CEO Dr...
06/1/202522:34EDGAR2Form 8-K - Current report
06/1/202514:30GLOBEQuoin Pharmaceuticals Announces Additional Positive Interim..
02/1/202523:20EDGAR2Form SCHEDULE 13D - General Statement of Acquisition of..
02/1/202523:20EDGAR2Form SCHEDULE 13D - General Statement of Acquisition of..
27/12/202423:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202423:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202423:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202415:00EDGAR2Form 8-K - Current report
23/12/202415:01EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
20/12/202415:20GLOBEQuoin Pharmaceuticals Announces Pricing of $6.8 Million..
19/12/202415:00EDGAR2Form 8-K - Current report
19/12/202414:00GLOBEQuoin Pharmaceuticals Announces FDA Clearance to Initiate..
18/12/202422:01EDGAR2Form S-1/A - General form for registration of securities..
18/12/202414:18GLOBEQuoin Pharmaceuticals Announces Positive Interim Data from..
11/12/202422:20EDGAR2Form S-1 - General form for registration of securities under..
10/12/202422:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/12/202422:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/12/202422:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/12/202422:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/12/202422:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/12/202422:30EDGAR2Form 8-K - Current report
15/11/202401:23EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
08/11/202423:04EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
08/11/202422:04EDGAR2Form 8-K - Current report
07/11/202414:00GLOBEQuoin Pharmaceuticals Provides Corporate Update and..
05/11/202414:00GLOBEQuoin Pharmaceuticals Initiates Clinical Testing of Lead..
31/10/202421:30EDGAR2Form 8-K - Current report
31/10/202421:05GLOBEQuoin Pharmaceuticals to Announce Third Quarter 2024..
24/10/202412:15EDGAR2Form DEF 14A - Other definitive proxy statements
22/10/202414:00GLOBEQuoin Pharmaceuticals Announces Further International..
11/10/202422:56EDGAR2Form PRE 14A - Other preliminary proxy statements
30/9/202412:07EDGAR2Form 8-K - Current report
11/9/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/9/202414:30GLOBEQuoin Pharmaceuticals Announces Insider Share Purchases by..
05/9/202418:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202418:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/8/202422:32EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
Apertura: Min: Max:
Chiusura: 0,3098

La tua Cronologia

NASDAQ
QNRX
Quoin Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci